title: Smoking Lung Cancer Patients and Tobacco Cessation - Is the Current Treatment in Germany Sufficient?
abstract: Lung cancer is the most preventable neoplastic disease for men and women. The incidence rate per year is 14.000 in Germany. Smoking is the main risk factor for the onset of lung cancer and for a share of 90% of cases, lung cancer is associated with smoking. Recent studies have shown that the time slot of diagnosing lung cancer is a teachable moment for tobacco cessation interventions. The therapy that was rated most effective was a combination of cognitive behavioral therapy and pharmacotherapy (e. g. NRT, Bupropion, Varenicline). We examined the smoking status of all patients undergoing lung cancer surgery in 2011, 2012 and 2013 in this study. A retrospective semi structured interview via telephone was conducted regarding smoking habits and current quality of life. 131 patients (36.6% female, average age of 68.7 years) of an urban German hospital were included.Results showed a relapse rate of 22.3%, while 86.2% used to be highly addicted smokers; A multivariate analysis of covariance (MANCOVA) indicated a significant overall impact of smoking status on quality of life with a medium effect size, controlled for age, gender, living conditions, tumor stage, duration of smoking abstinence, type of cancer therapy, type of resection method, and the time period between the date of surgery and of the survey. Two thirds of all smokers did not see an association between their habit and their disease.So far motivation to quit and long term abstinence rates are not sufficiently established even among seriously sick patients in Germany; further initiatives should focus on new and more intense interventions and educational strategies.
authors.affiliation: Vivantes - Netzwerk für Gesundheit GmbH, Berlin.
authors.forename: K
authors.initials: K
authors.lastname: Vitzthum
authors.affiliation: Humboldt University Berlin - Institute of Psychology.
authors.forename: L
authors.initials: L
authors.lastname: Thielke
authors.affiliation: Institute of Occupational Medicine - Charité - Universitymedicine Berlin.
authors.forename: A
authors.initials: A
authors.lastname: Deter
authors.affiliation: Humboldt University Berlin - Institute of Psychology.
authors.forename: T
authors.initials: T
authors.lastname: Riemer
authors.affiliation: Vivantes - Netzwerk für Gesundheit GmbH, Berlin.
authors.forename: S
authors.initials: S
authors.lastname: Eggeling
authors.affiliation: Vivantes - Netzwerk für Gesundheit GmbH, Berlin.
authors.forename: W
authors.initials: W
authors.lastname: Pankow
authors.affiliation: Institute of Occupational, Social and Environmental Medicine - Hamburg.
authors.forename: S
authors.initials: S
authors.lastname: Mache
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D015897:Comorbidity; D005260:Female; D005858:Germany / Q000453:epidemiology; D019538:Health Care Surveys; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology* / Q000517:prevention & control* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011788:Quality of Life; D012189:Retrospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D012907:Smoking / Q000453:epidemiology*; D000074606:Smoking Prevention; D020340:Tobacco Use Cessation / Q000706:statistics & numerical data*; D016896:Treatment Outcome; D014600:Utilization Review; D055815:Young Adult